These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22674300)

  • 1. Altered desialylated plasma N-glycan profile in patients with non-small cell lung carcinoma.
    Bartling B; Vanhooren V; Dewaele S; Libert C; Hofmann HS; Haerting J; Nuding S; Silber RE; Simm A; Chen CC
    Cancer Biomark; 2011-2012; 10(3-4):145-54. PubMed ID: 22674300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haptoglobin and posttranslational glycan-modified derivatives as serum biomarkers for the diagnosis of nonsmall cell lung cancer.
    Hoagland LF; Campa MJ; Gottlin EB; Herndon JE; Patz EF
    Cancer; 2007 Nov; 110(10):2260-8. PubMed ID: 17918261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human serum N-glycan profiles are age and sex dependent.
    Ding N; Nie H; Sun X; Sun W; Qu Y; Liu X; Yao Y; Liang X; Chen CC; Li Y
    Age Ageing; 2011 Sep; 40(5):568-75. PubMed ID: 21807702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidant stress and B vitamins status in patients with non-small cell lung cancer.
    Tsao SM; Yin MC; Liu WH
    Nutr Cancer; 2007; 59(1):8-13. PubMed ID: 17927496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-glycan profiles as tools in diagnosis of hepatocellular carcinoma and prediction of healthy human ageing.
    Vanhooren V; Liu XE; Franceschi C; Gao CF; Libert C; Contreras R; Chen C
    Mech Ageing Dev; 2009; 130(1-2):92-7. PubMed ID: 19070631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood group antigen A and flow cytometric analysis in resected early-stage non-small cell lung cancer.
    Graziano SL; Tatum AH; Gonchoroff NJ; Newman NB; Kohman LJ
    Clin Cancer Res; 1997 Jan; 3(1):87-93. PubMed ID: 9815542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered serum N-glycomics in chronic hepatitis B patients.
    Gui HL; Gao CF; Wang H; Liu XE; Xie Q; Dewaele S; Wang L; Zhuang H; Contreras R; Libert C; Chen C
    Liver Int; 2010 Feb; 30(2):259-67. PubMed ID: 19951379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of utility of plasma TNF-alpha level in predicting therapeutic efficacy in patients with advanced non-small cell lung cancer.
    Kumar S; Guleria R; Singh V; Mohan A; Bharti AC; Das BC
    Cytokine; 2010 Sep; 51(3):245-8. PubMed ID: 20599393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrimination of clinical stages in non-small cell lung cancer patients by serum HSP27 and HSP70: a multi-institutional case-control study.
    Zimmermann M; Nickl S; Lambers C; Hacker S; Mitterbauer A; Hoetzenecker K; Rozsas A; Ostoros G; Laszlo V; Hofbauer H; Renyi-Vamos F; Klepetko W; Dome B; Ankersmit HJ
    Clin Chim Acta; 2012 Jul; 413(13-14):1115-20. PubMed ID: 22465083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum miR-499 as a novel diagnostic and prognostic biomarker in non-small cell lung cancer.
    Li M; Zhang Q; Wu L; Jia C; Shi F; Li S; Peng A; Zhang G; Song X; Wang C
    Oncol Rep; 2014 Apr; 31(4):1961-7. PubMed ID: 24549225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel detection method of non-small cell lung cancer using multiplexed bead-based serum biomarker profiling.
    Lee HJ; Kim YT; Park PJ; Shin YS; Kang KN; Kim Y; Kim CW
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):421-7. PubMed ID: 22104668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of pretreatment plasma levels of insulin-like growth factor (IGF)-1, IGF-2, and IGF binding protein-3 in patients with advanced non-small cell lung cancer.
    Han JY; Choi BG; Choi JY; Lee SY; Ju SY
    Lung Cancer; 2006 Nov; 54(2):227-34. PubMed ID: 16935391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Level of cytokeratin-19 in serum of patients with non small cell lung cancer].
    Cynowska B; Słomiński JM; Wyrwiński J
    Pneumonol Alergol Pol; 1995; 63(11-12):615-20. PubMed ID: 8616476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.
    Paci M; Maramotti S; Bellesia E; Formisano D; Albertazzi L; Ricchetti T; Ferrari G; Annessi V; Lasagni D; Carbonelli C; De Franco S; Brini M; Sgarbi G; Lodi R
    Lung Cancer; 2009 Apr; 64(1):92-7. PubMed ID: 18804892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer.
    Mizuguchi S; Nishiyama N; Iwata T; Nishida T; Izumi N; Tsukioka T; Inoue K; Uenishi T; Wakasa K; Suehiro S
    Lung Cancer; 2007 Dec; 58(3):369-75. PubMed ID: 17697728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes.
    Sher YP; Shih JY; Yang PC; Roffler SR; Chu YW; Wu CW; Yu CL; Peck K
    Clin Cancer Res; 2005 Jan; 11(1):173-9. PubMed ID: 15671543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor volume and tumor marker index based on CYFRA 21-1 and CEA are strong prognostic factors in operated early stage NSCLC.
    Muley T; Fetz TH; Dienemann H; Hoffmann H; Herth FJ; Meister M; Ebert W
    Lung Cancer; 2008 Jun; 60(3):408-15. PubMed ID: 18083270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment serum levels of cytokines and cytokine receptors in patients with non-small cell lung cancer, and correlations with clinicopathological features and prognosis. M-CSF - an independent prognostic factor.
    Kaminska J; Kowalska M; Kotowicz B; Fuksiewicz M; Glogowski M; Wojcik E; Chechlinska M; Steffen J
    Oncology; 2006; 70(2):115-25. PubMed ID: 16645324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum concentrations of proinflammatory cytokines in advanced non small cell lung cancer patients.
    De Vita F; Orditura M; Auriemma A; Infusino S; Catalano G
    J Exp Clin Cancer Res; 1998 Dec; 17(4):413-7. PubMed ID: 10089060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum reactive oxygen species modulator 1 (Romo1) as a potential diagnostic biomarker for non-small cell lung cancer.
    Lee SH; Lee JS; Lee EJ; Min KH; Hur GY; Lee SH; Lee SY; Kim JH; Lee SY; Shin C; Shim JJ; Kang KH; In KH
    Lung Cancer; 2014 Aug; 85(2):175-81. PubMed ID: 24951318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.